The effect of potent antiretroviral therapy and JC virus load in cerebrospinal fluid on clinical outcome of patients with AIDS-associated progressive multifocal leukoencephalopathy

A. De Luca, M. L. Giancola, A. Ammassari, S. Grisetti, M. G. Paglia, M. Gentile, A. Cingolani, R. Murri, G. Liuzzi, A. D'Arminio Monforte, A. Antinori

Research output: Contribution to journalArticle

Abstract

A multicenter analysis of 57 consecutive human immunodeficiency virus-positive patients with progressive multifocal leukoencephalopathy (PML) was performed, to identify correlates of longer survival. JC virus (JCV) DNA was quantified in the cerebrospinal fluid (CSF) by polymerase chain reaction. Two months after therapy, 4% of the patients without highly active antiretroviral therapy (HAART) and 26% with HAART showed neurologic improvement or stability (P = .03), and 8% and 57%, respectively, reached undetectable JCV DNA levels in the CSF (P = .04). One-year probability of survival was .04 without HAART and .46 with HAART. HAART and lack of neurologic progression 2 months after diagnosis were independently associated with longer survival. Among HAART-treated patients, a baseline JCV DNA

Original languageEnglish
Pages (from-to)1077-1083
Number of pages7
JournalJournal of Infectious Diseases
Volume182
Issue number4
DOIs
Publication statusPublished - 2000

ASJC Scopus subject areas

  • Immunology
  • Public Health, Environmental and Occupational Health

Fingerprint Dive into the research topics of 'The effect of potent antiretroviral therapy and JC virus load in cerebrospinal fluid on clinical outcome of patients with AIDS-associated progressive multifocal leukoencephalopathy'. Together they form a unique fingerprint.

  • Cite this